Childhood pneumonia as a global health priority and the strategic interest of the bill & Melinda Gates Foundation

Clinical Infectious Diseases

Volumn 54, Issue SUPPL. 2, 2012, Pages

  Adegbola, Richard A ^a  

^a BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; DEVELOPING COUNTRY; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNIZATION; INFLUENZA VIRUS; LOWER RESPIRATORY TRACT INFECTION; MENINGITIS; MICROORGANISM DETECTION; NON PROFIT ORGANIZATION; OTITIS MEDIA; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; STRATEGIC PLANNING; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; VIRUS PNEUMONIA;

BACTERIAL VACCINES; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DEVELOPING COUNTRIES; FOUNDATIONS; HEALTH PLANNING SUPPORT; HEALTH PRIORITIES; HUMANS; INFANT; PNEUMOCOCCAL VACCINES; PNEUMONIA; RESEARCH SUPPORT AS TOPIC; STREPTOCOCCUS PNEUMONIAE; WORLD HEALTH;

EID: 84858139996     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir1051     Document Type: Article

References (21)

1. Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010; 375:1969-87.
2. Rajaratnam JK, Marcus JR, Flaxman D, et al. Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet 2010; 375:1988-2008.
3. Enserink M. Global Health-Some neglected diseases aremore neglected than others. Science 2009; 323:700.
4. United Nations Children's Fund/World Health Organization. Pneumonia. The forgotten killer of children. New York, NY: United Nations Children's Fund/World Health Organization; 2006.
5. World Health Assembly. Accelerated progress towards achievement of Millennium Development Goal 4 to reduce child mortality: prevention and treatment of pneumonia WHA 63.24. World Health Organization; 2010.
6. Greenwood BM, Weber MW, Mulholland K. Childhood pneumonia-preventing the world's biggest killer of children. Bull World Health Organ 2007; 85:502-3. (Pubitemid 47041627)
7. World Health Organization/United Nations Children's Fund. Global action plan for prevention and control of pneumonia (GAPP). New York: World Health Organization/United Nations Children's Fund, 2009.
8. Shann F. Etiology of severe pneumonia in children in developing countries. Paediatr Infect Dis 1986; 5:247-52. (Pubitemid 16162869)
9. World Health Organization. Programme for the control of acute respiratory infections: Technical bases for the WHO recommendations on the management of pneumonia in children at first-level health facilities. Geneva: World Health Organization, 1991. WHO/ARI/91.20.
10. Selwyn BJ. Coordinated Data Group of BOSTID Researchers. The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Rev Infect Dis 1990; 12(Suppl 8):S870-88.
11. Levine OS, Cherian T, Hajjeh R, Knoll M. Progress and future challenges in coordinated surveillance and detection of pneumococcal and Hib disease in developing countries. Clin Infect Dis 2009; 48:S33-6.
12. O'Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374:893-902.
13. Madhi SA, Petersen K, Madhi A, et al. Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children. Pediatri Infect Dis J 2000; 19:1141-7. (Pubitemid 32003356)
14. Scott JA, English M. What are the implications for childhood pneumonia of successfully introducing Hib and pneumococcal vaccines in developing countries? PLoS Med 2008; 5:e86.
15. Adegbola RA, Secka O, Lahai G, et al. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Lancet 2005; 366:144-50. (Pubitemid 40991215)
16. Cowgill KD, Ndiritu M, Nyiro J, et al. Effectiveness of Haemophilus influenzae type b conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA 2006; 296:671-8. (Pubitemid 44200638)
17. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19:187-95. (Pubitemid 30167436)
18. Klugman KP, Madhi SA, Huebner RE, et al. Vaccine Trialists Group. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349: 1341-8. (Pubitemid 37186212)
19. Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005; 365:1139-46. (Pubitemid 40417563)
20. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348:1737-46. (Pubitemid 36514704)
21. Ojo L, O'Loughlin R, Cohen AL, et al. Global use of Haemophilus influenzae type b conjugate vaccine: an update of accelerated adoption in the developing world. Vaccine 2010; 28:7117-22.